Saturday, 23 September 2017

Roche cancer immunotherapy Tecentriq wins EU approval

ZURICH (Reuters) - Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)